all report title image

PIGMENTATION DISORDERS TREATMENT MARKET ANALYSIS

Pigmentation Disorders Treatment Market, By Disorder Type (Melasma, Vitiligo, Albinism, Post-Inflammatory Hyperpigmentation (PIH), and Others), By Drug Type (Corticosteroids, Calcineurin Inhibitors, Janus kinase inhibitor, Melanin Synthesis Inhibitor, and Others), By Route of Administration (Oral, Topical, and Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Apr 2024
  • Code : CMI5421
  • Pages :172
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Pigmentation Disorders Treatment Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Market Driver – Increasing Awareness About Pigmentation Disorders

With the increasing usage of social media and digital mediums, awareness about various skin conditions including pigmentation disorders has grown tremendously over the past decade. There is a rising knowledge amongst people about various skin conditions leading to uneven skin tone and patches. Various international non-profit organizations like International Dermatology Foundation and Melanoma Research Alliance are actively working to educate people on identifying signs of pigmentation disorders and encouraging them to seek medical guidance without any hesitation. Their efforts on social media and online awareness campaigns are helping remove the stigma around such skin conditions and normalize discussing them. This is allowing more individuals suffering from pigmentation issues like melasma, vitiligo or post inflammatory hyperpigmentation to openly consult doctors without fear. As a result, demand for topical creams, laser therapies and other treatment options available is surging across global markets. As per UN World Population Prospects report, nearly 1.7 billion people accessed internet worldwide by 2023, up from 3.2 billion in 2015. This points towards rising scope of virtual awareness drives impacting treatment-seeking behavior positively.

Key Players Insights
  • Abbvie Inc. 
  • Edesa Biotech, Inc.
  • Amgen, Inc.
  • Pfizer Inc.
  • CLINUVEL PHARMACEUTICALS LTD
  • Uniza Group
  • Dr. Reddy’s Laboratories Ltd.
  • Roivant Sciences Ltd.
  • Incyte
  • Aclaris Therapeutics, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • GSK plc.
  • Vyne Therapeutics Inc.
  • Temprian Therapeutics Inc.
  • Arrien Pharmaceuticals, LLC

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.